Casey Woodring
Stock Analyst at J.P. Morgan
(4.43)
# 1,196
Out of 5,116 analysts
231
Total ratings
64.2%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Rated: Buy | $460 → $405 | $310.67 | +30.36% | 8 | Nov 6, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $130 → $135 | $113.94 | +18.48% | 9 | Nov 5, 2026 | |
| BRKR Bruker | Reiterated: Hold | $60 | $61.31 | -2.14% | 6 | Nov 5, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $345 → $385 | $337.52 | +14.07% | 24 | Nov 5, 2026 | |
| TEM Tempus AI | Reiterated: Hold | $70 → $80 | $76.05 | +5.19% | 7 | Nov 5, 2026 | |
| RVTY Revvity | Reiterated: Hold | $155 → $160 | $155.11 | +3.15% | 6 | Nov 4, 2026 | |
| SHC Sotera Health Company | Reiterated: Sell | $17 → $15 | $16.01 | -6.31% | 17 | Nov 4, 2026 | |
| WAT Waters | Reiterated: Hold | $435 → $470 | $457.60 | +2.71% | 8 | Nov 4, 2026 | |
| ILMN Illumina | Reiterated: Buy | $320 → $300 | $213.13 | +40.76% | 10 | Oct 30, 2026 | |
| AVTR Avantor | Reiterated: Hold | $15 → $17 | $15.47 | +9.89% | 5 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $165 → $200 | $204.74 | -2.32% | 20 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $205 | $173.49 | +18.16% | 6 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $295 → $325 | $271.83 | +19.56% | 4 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $250 → $270 | $230.25 | +17.26% | 10 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $760 → $820 | $694.76 | +18.03% | 8 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $52 | $50.33 | +3.32% | 22 | Oct 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1,400 → $1,550 | $1,722.15 | -10.00% | 6 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $70 | $59.28 | +18.08% | 6 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $27.98 | +7.22% | 1 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $35 | $25.23 | +38.72% | 6 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $150.87 | +29.25% | 8 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $12 | $10.70 | +12.15% | 21 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $190 | $174.76 | +8.72% | 5 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $35 | $28.05 | +24.78% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.44 | n/a | 5 | Aug 9, 2024 |
Natera
Nov 6, 2026
Rated: Buy
Price Target: $460 → $405
Current: $310.67
Upside: +30.36%
BillionToOne
Nov 5, 2026
Reiterated: Buy
Price Target: $130 → $135
Current: $113.94
Upside: +18.48%
Bruker
Nov 5, 2026
Reiterated: Hold
Price Target: $60
Current: $61.31
Upside: -2.14%
Charles River Laboratories International
Nov 5, 2026
Reiterated: Buy
Price Target: $345 → $385
Current: $337.52
Upside: +14.07%
Tempus AI
Nov 5, 2026
Reiterated: Hold
Price Target: $70 → $80
Current: $76.05
Upside: +5.19%
Revvity
Nov 4, 2026
Reiterated: Hold
Price Target: $155 → $160
Current: $155.11
Upside: +3.15%
Sotera Health Company
Nov 4, 2026
Reiterated: Sell
Price Target: $17 → $15
Current: $16.01
Upside: -6.31%
Waters
Nov 4, 2026
Reiterated: Hold
Price Target: $435 → $470
Current: $457.60
Upside: +2.71%
Illumina
Oct 30, 2026
Reiterated: Buy
Price Target: $320 → $300
Current: $213.13
Upside: +40.76%
Avantor
Oct 29, 2026
Reiterated: Hold
Price Target: $15 → $17
Current: $15.47
Upside: +9.89%
Oct 29, 2026
Reiterated: Hold
Price Target: $165 → $200
Current: $204.74
Upside: -2.32%
Oct 29, 2026
Reiterated: Buy
Price Target: $200 → $205
Current: $173.49
Upside: +18.16%
Oct 28, 2026
Rated: Buy
Price Target: $295 → $325
Current: $271.83
Upside: +19.56%
Oct 22, 2026
Rated: Buy
Price Target: $250 → $270
Current: $230.25
Upside: +17.26%
Oct 22, 2026
Reiterated: Buy
Price Target: $760 → $820
Current: $694.76
Upside: +18.03%
Oct 21, 2026
Downgraded: Hold
Price Target: $55 → $52
Current: $50.33
Upside: +3.32%
Oct 16, 2026
Reiterated: Hold
Price Target: $1,400 → $1,550
Current: $1,722.15
Upside: -10.00%
Oct 16, 2026
Reiterated: Hold
Price Target: $50 → $70
Current: $59.28
Upside: +18.08%
Oct 14, 2026
Reiterated: Buy
Price Target: $30
Current: $27.98
Upside: +7.22%
Oct 14, 2026
Reiterated: Buy
Price Target: $25 → $35
Current: $25.23
Upside: +38.72%
Oct 14, 2026
Reiterated: Buy
Price Target: $195
Current: $150.87
Upside: +29.25%
Oct 14, 2026
Reiterated: Sell
Price Target: $12
Current: $10.70
Upside: +12.15%
Aug 27, 2026
Reiterated: Buy
Price Target: $180 → $190
Current: $174.76
Upside: +8.72%
Aug 10, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $28.05
Upside: +24.78%
Aug 9, 2024
Reiterated: Hold
Price Target: $6 → $5
Current: $3.44
Upside: n/a